CLINICAL_TRIALS
trial_result
· 2020-09-04
Clinical Trial Update: Antiarrhythmic Effects of Spironolactone in Patients With ICDs [Phase 4]
Summary
Phase 4 trial update evaluating antiarrhythmic effects of spironolactone in patients with implantable cardioverter-defibrillators; results posted after completi…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: VA Office of Research and Development | Conditions: Ventricular Arrhythmias | Phase 4 | Status: COMPLETED | Results posted: 2020-09-04